Alex Michie - Director ClinicaGeno Ltd. (United Kingdom)
Alex is ClinicaGeno's director in Europe and holds a Bioinformatics PhD from University College London and an MBA from the Rotterdam School of Management. He has extensive experience in cross-domain projects bridging diverse areas of science and IT. Alex's experience is particularly in projects that are related to scientific data analysis and FDA/EU medical device submissions where compliance to regulatory standards is critical. For instance, prior to starting ClinicaGeno, Alex had a major role in the development of the IT infrastructure for a cancer diagnostic application that has been submitted for certification by the FDA.
Alex is ClinicaGeno's director in Europe and holds a Bioinformatics PhD from University College London and an MBA from the Rotterdam School of Management. He has extensive experience in cross-domain projects bridging diverse areas of science and IT. Alex's experience is particularly in projects that are related to scientific data analysis and FDA/EU medical device submissions where compliance to regulatory standards is critical. For instance, prior to starting ClinicaGeno, Alex had a major role in the development of the IT infrastructure for a cancer diagnostic application that has been submitted for certification by the FDA.
Thomas Binsl - Director ClinicaGeno Analytics (B.C., Canada)
Thomas holds a Bioinformatics PhD from the VU University Amsterdam and has extensive experience in the development of data-based solutions, the analysis of biological/medical as well as developing validated software for new medical diagnostic products. Currently, he is in charge of planning, developing and managing the analysis and IT infrastructure for IS-Diagnostics' and TubaScan's diagnotic products. In addition, Thomas is also exploring new opportunities in the North American market via our new subsidiary in Victoria BC, Canada.
Thomas holds a Bioinformatics PhD from the VU University Amsterdam and has extensive experience in the development of data-based solutions, the analysis of biological/medical as well as developing validated software for new medical diagnostic products. Currently, he is in charge of planning, developing and managing the analysis and IT infrastructure for IS-Diagnostics' and TubaScan's diagnotic products. In addition, Thomas is also exploring new opportunities in the North American market via our new subsidiary in Victoria BC, Canada.